pH-dependent chalcogenopyrylium dyes as potential sensitizers for photodynamic therapy: Selective retention in tumors by exploiting pH differences between tumor and normal tissue

被引:17
作者
Bellnier, DA
Young, DN
Detty, MR
Camacho, SH
Oseroff, AR
机构
[1] Roswell Pk Canc Inst, PDT Ctr, Buffalo, NY 14263 USA
[2] SUNY Buffalo, Sch Pharm, Dept Med Chem, Buffalo, NY 14260 USA
[3] Roswell Pk Canc Inst, Dept Dermatol, Buffalo, NY USA
关键词
D O I
10.1111/j.1751-1097.1999.tb08262.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ideal photosensitizers have long-wavelength absorption and strong tumor selectivity with rapid clearance from normal tissues. The telluroselenopyrylium dye 1 that absorbs light at 795 nm (epsilon = 285 000 M-1 cm(-1)) has a novel property that enhances the tumor specificity and normal tissue clearance. After intralesional injection to both tumors and surrounding skin, it disappeared from the normal skin of BALB/c mice faster than it did from subcutaneously implanted Colon 26 tumors, which resulted in therapeutic selectivity. In who reflectance spectroscopy showed that the half-life in tumor was about 50 min while in skin it was around 12 min, This phenomenon appears to be related to the pH differences in normal skin versus tumor, because the rates of drug hydrolysis in solution were shown to be sensitive to changes in pH. Inhibition of tumor regrowth;th following intratumoral photosensitizer administration depended on both light dose and drug dose, as well as the time interval between dye injection and irradiation; selectivity depended on the time interval. Although treatment parameters were not optimized efficacy was superior to systemic Photofrin(R) under our standard conditions. We discuss how new, more optimal, photosensitizers can be designed that use rates of hydrolysis to exploit the differences in pH between normal tissue and tumor.
引用
收藏
页码:630 / 636
页数:7
相关论文
共 24 条
[1]  
BALABAN AT, 1982, ADV HETEROCYCLIC C S, V2, P66
[2]  
CINCOTTA L, 1994, CANCER RES, V54, P1249
[3]   CHALCOGENAPYRYLIUM DYES AS PHOTOCHEMOTHERAPEUTIC AGENTS .2. TUMOR UPTAKE, MITOCHONDRIAL TARGETING, AND SINGLET-OXYGEN-INDUCED INHIBITION OF CYTOCHROME-C OXIDASE [J].
DETTY, MR ;
MERKEL, PB ;
HILF, R ;
GIBSON, SL ;
POWERS, SK .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (04) :1108-1116
[4]  
DETTY MR, 1992, ONCOL RES, V4, P367
[5]   Photodynamic therapy [J].
Dougherty, TJ ;
Gomer, CJ ;
Henderson, BW ;
Jori, G ;
Kessel, D ;
Korbelik, M ;
Moan, J ;
Peng, Q .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12) :889-905
[6]  
DOUGHERTY TJ, 1995, CRC HDB ORGANIC PHOT, P1384
[7]  
EDEN M, 1955, J NATL CANCER I, V16, P541
[8]   EXTRACELLULAR PH AS A PROGNOSTIC FACTOR IN THERMORADIOTHERAPY [J].
ENGIN, K ;
LEEPER, DB ;
THISTLETHWAITE, AJ ;
TUPCHONG, L ;
MCFARLANE, JD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (01) :125-132
[9]   EXTRACELLULAR PH DISTRIBUTION IN HUMAN TUMORS [J].
ENGIN, K ;
LEEPER, DB ;
CATER, JR ;
THISTLETHWAITE, AJ ;
TUPCHONG, L ;
MCFARLANE, JD .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1995, 11 (02) :211-216
[10]   PRECLINICAL EXAMINATION OF 1ST AND 2ND GENERATION PHOTOSENSITIZERS USED IN PHOTODYNAMIC THERAPY [J].
GOMER, CJ .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1991, 54 (06) :1093-1107